Latest Content

Personalized Neoantigen Vaccines Show Lasting Tumor Control in Kidney Cancer

July 19th 2025, 6:00pm

By Ashling Wahner

Article

Early data suggest personalized neoantigen vaccines activate the immune system and sustain tumor control in some patients with kidney cancer.

High-Fiber Diet Linked to Better Treatment Responses in Skin Cancer

July 19th 2025, 2:00pm

By Ryan Scott

Article

Patients with skin cancer who were fed a high-fiber diet showed better response rates to treatment and longer event-free survival, according to data from the DIET trial.

What Makes a Quality Cancer Support Group?

July 18th 2025, 9:00pm

By Sue McCarthy

Article

After attending several cancer support groups, I reflect on what makes them helpful, inclusive and healing — and invite others to share their insights too.

How Personalized Cancer Vaccines Are Advancing Kidney Cancer Care

July 18th 2025, 8:00pm

By Dr. David A. Braun

Video

Personalized cancer vaccines may potentially represent a step forward in guiding the immune system to more precisely target kidney cancer.

Lung Cancer Study Links Treatment History to Quality-of-Life Differences

July 18th 2025, 7:00pm

By Spencer Feldman

Article

Quality-of-life in lung cancer varies, with certain treatments leading to sleep-related issues, pain, and emotional changes depending on disease stage.

Max The Butterfly: Hope and Resurrection After Cancer

July 18th 2025, 5:00pm

By Jane Biehl Ph.D.

Article

Butterflies are believed to be a symbol of resurrection and hope. This is an inspiring story about this phenomenon.

FDA Votes Against Proposed Blenrep Treatment Combo’s for Multiple Myeloma

July 18th 2025, 4:00pm

By Ryan Scott

Article

The FDA's Oncologic Drugs Advisory Committee has casted their votes on the utilization of certain treatments in the multiple myeloma patient population.

FDA Grants Priority Review to TAR-200 for Bladder Cancer Subset

July 18th 2025, 3:00pm

By Spencer Feldman

Article

FDA grants priority review to TAR-200, which demonstrated an 82% complete response in high-risk bladder cancer unresponsive to Bacillus Calmette-Guérin.

Ojjaara May Improve Anemia and Reduce Transfusions in Myelofibrosis

July 18th 2025, 1:00pm

By Dr. Francesca Palandri

Video

An expert highlights the impact of anemia in myelofibrosis and presented Ojjaara as a possible treatment to reduce transfusions and improve outcomes.

What’s in a Name? How I Chose ‘Person’ Over ‘Survivor’ After Cancer

July 17th 2025, 9:00pm

By Karen Cohn

Article

When asked to choose a word other than “survivor” to describe myself, I chose “person” because cancer does not define who I am.

Regaining Independence After Ovarian Cancer Surgery

July 17th 2025, 8:00pm

By Mary Barbera

Video

After ovarian cancer surgery, Mary Barbera spent three months in rehab before finally returning home, a milestone that marked her emotional recovery.

Enhertu Combo Receives FDA Designation in Metastatic HER2+ Breast Cancer

July 17th 2025, 7:13pm

By Ryan Scott

Article

The FDA granted breakthrough therapy designation to first-line treatment with Enhertu plus Perjeta for unresectable or metastatic HER2+ breast cancer.

Writing Helped Me Heal After Pancreatic Cancer

July 17th 2025, 5:00pm

By William Ramshaw

Article

Cancer leaves deep emotional scars long after treatment ends, but for many survivors, honest, unfiltered writing can be a powerful path to healing.

Key Skin Cancer Treatment Updates From 2025 and What is Still to Come

July 17th 2025, 4:05pm

By Ryan Scott

Article

Dr. Ma discussed key findings that have been shared so far this year on the topic of evolving treatment strategies for patients with high-risk skin cancer.

FDA Grants Orphan Status to Liquid Glioma Treatment SH-110

July 17th 2025, 3:14pm

By Spencer Feldman

Article

SH-110, a liquid cancer treatment for glioma, earned orphan drug status from the FDA, helping patients who struggle to swallow pills access therapy.